Prognostic Factors , Morbidity and Mortality in Patients With Neuromuscular Disorders Admitted in ICU
NCT ID: NCT02685215
Last Updated: 2019-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
800 participants
OBSERVATIONAL
2016-03-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Dysfunction in Critical Illness
NCT03717831
Biomechanical Properties in Intensive Care Unit (ICU) Survivors 12-month After Discharge
NCT01364714
Skeletal Muscle Wasting in ICU Patients
NCT06234826
Muscle Function After Intensive Care
NCT03922113
Muscle Function and Muscle Ultrasound in ICU
NCT04696497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Duchenne muscular dystrophy
* Becker muscular dystrophy
* LGMD
* Steinert disease
* Pompe disease
* FSHD
* metabolic disease
* mitochondrial disease
* congenital myopathy
* others neuro-muscular diseases
Exclusion Criteria
* minor patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Investigation Clinique et Technologique 805
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdallah FAYSSOIL
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
abdallah Fayssoil, MDPhD
Role: PRINCIPAL_INVESTIGATOR
Raymond Poincare Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Raymond Poincare
Garches, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1912677
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.